These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 37476077

  • 1. Clinical Characteristics and Outcome of Ceftazidime/Avibactam-Resistant Klebsiella pneumoniae Carbapenemase-Producing Klebsiella pneumoniae Infections: A Retrospective, Observational, 2-Center Clinical Study.
    Oliva A, Campogiani L, Savelloni G, Vitale P, Lodi A, Sacco F, Imeneo A, Volpicelli L, Polani R, Raponi G, Sarmati L, Venditti M.
    Open Forum Infect Dis; 2023 Jul; 10(7):ofad327. PubMed ID: 37476077
    [Abstract] [Full Text] [Related]

  • 2. Ceftazidime/avibactam-resistant meropenem-susceptible KPC-producing Klebsiella pneumoniae: Analysis of cases and evaluation of in vitro activity of fosfomycin-containing combinations.
    Oliva A, Al Ismail D, Arcari G, Miele MC, Casali E, Sacco F, Volpicelli L, De Angelis M, Mascellino MT, Cancelli F, Raponi G, Carattoli A, Venditti M.
    J Glob Antimicrob Resist; 2023 Jun; 33():321-327. PubMed ID: 37086891
    [Abstract] [Full Text] [Related]

  • 3. Deciphering variable resistance to novel carbapenem-based β-lactamase inhibitor combinations in a multi-clonal outbreak caused by Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam.
    Di Pilato V, Principe L, Andriani L, Aiezza N, Coppi M, Ricci S, Giani T, Luzzaro F, Rossolini GM.
    Clin Microbiol Infect; 2023 Apr; 29(4):537.e1-537.e8. PubMed ID: 36414199
    [Abstract] [Full Text] [Related]

  • 4. Reversion of KPC-114 to KPC-2 in ceftazidime-avibactam- resistant/meropenem-susceptible Klebsiella pneumoniae ST11 is related to low mutation rates.
    Pariona JGM, Vásquez-Ponce F, Becerra J, Martins-Gonçalves T, Pariona EMM, Madueño FT, Esposito F, V de Lima A, Mello Sampaio JL, Galhardo RS, Lincopan N.
    Microbiol Spectr; 2024 Oct 03; 12(10):e0117324. PubMed ID: 39190636
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics and Efficacy of Ceftazidime-Avibactam in the Treatment of Experimental Pneumonia Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Persistently Neutropenic Rabbits.
    Petraitiene R, Petraitis V, Kavaliauskas P, Maung BBW, Khan F, Naing E, Aung T, Zigmantaite V, Grigaleviciute R, Kucinskas A, Stakauskas R, Georgiades BN, Mazur CA, Hayden JA, Satlin MJ, Walsh TJ.
    Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 32015048
    [Abstract] [Full Text] [Related]

  • 6. Prevalence and mortality of ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae bloodstream infections (2018-2022).
    Boattini M, Bianco G, Bastos P, Comini S, Corcione S, Almeida A, Costa C, De Rosa FG, Cavallo R.
    Eur J Clin Microbiol Infect Dis; 2024 Jan 24; 43(1):155-166. PubMed ID: 37985552
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characteristic of KPC-12, a KPC Variant Conferring Resistance to Ceftazidime-Avibactam in the Carbapenem-Resistant Klebsiella pneumoniae ST11-KL47 Clone Background.
    Han W, Zhou P, Chen C, Wu C, Shen L, Wan C, Xiao Y, Zhang J, Wang B, Shi J, Yuan X, Gao H, Wang H, Zhou Y, Yu F.
    Infect Drug Resist; 2024 Jan 24; 17():2541-2554. PubMed ID: 38933778
    [Abstract] [Full Text] [Related]

  • 12. [Evaluation of In Vitro Efficacy of Ceftazidime-Avibactam, Meropenem, and Colistin Single and Binary Combinations Against Carbapenem Resistant Klebsiella pneumoniae Strains Isolated from Various Clinical Specimens].
    Köle M, Sesli Çetin E, Şirin MC, Cicioğlu Arıdoğan B.
    Mikrobiyol Bul; 2022 Apr 24; 56(2):230-250. PubMed ID: 35477227
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Meropenem/vaborbactam activity in vitro: a new option for Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae treatment.
    Romanelli F, Stolfa S, Morea A, Ronga L, Prete RD, Chironna M, Santacroce L, Mosca A.
    Future Microbiol; 2021 Nov 24; 16():1261-1266. PubMed ID: 34674551
    [Abstract] [Full Text] [Related]

  • 15. Identification of KPC-112 from an ST15 Klebsiella pneumoniae Strain Conferring Resistance to Ceftazidime-Avibactam.
    Shen S, Tang C, Ding L, Han R, Yin D, Yang W, Guo Y, Hu F.
    mSphere; 2022 Dec 21; 7(6):e0048722. PubMed ID: 36374086
    [Abstract] [Full Text] [Related]

  • 16. Diversity of Ceftazidime-Avibactam Resistance Mechanism in KPC2-Producing Klebsiella pneumoniae Under Antibiotic Selection Pressure.
    Jiang M, Sun B, Huang Y, Liu C, Wang Y, Ren Y, Zhang Y, Wang Y, Mu D.
    Infect Drug Resist; 2022 Dec 21; 15():4627-4636. PubMed ID: 36003991
    [Abstract] [Full Text] [Related]

  • 17. In vivo Selection of Imipenem Resistance Among Ceftazidime-Avibactam-Resistant, Imipenem-Susceptible Klebsiella pneumoniae Isolate With KPC-33 Carbapenemase.
    Wang C, Zhao J, Liu Z, Sun A, Sun L, Li B, Lu B, Liu Y, Cao B.
    Front Microbiol; 2021 Dec 21; 12():727946. PubMed ID: 34630354
    [Abstract] [Full Text] [Related]

  • 18. Dynamic evolution of ceftazidime-avibactam resistance due to interchanges between blaKPC-2 and blaKPC-145 during treatment of Klebsiella pneumoniae infection.
    Chen Y, Yang R, Guo P, Liu P, Deng J, Wu Z, Wu Q, Huang J, Liao K.
    Front Cell Infect Microbiol; 2023 Dec 21; 13():1244511. PubMed ID: 37671146
    [Abstract] [Full Text] [Related]

  • 19. Ceftazidime-avibactam resistance and restoration of carbapenem susceptibility in KPC-producing Klebsiella pneumoniae infections: A case series.
    van Asten SAV, Boattini M, Kraakman MEM, Bianco G, Iannaccone M, Costa C, Cavallo R, Bernards AT.
    J Infect Chemother; 2021 May 21; 27(5):778-780. PubMed ID: 33558042
    [Abstract] [Full Text] [Related]

  • 20. Emergence of a KPC Variant Conferring Resistance to Ceftazidime-Avibactam in a Widespread ST11 Carbapenem-Resistant Klebsiella pneumoniae Clone in China.
    Li X, Quan J, Ke H, Wu W, Feng Y, Yu Y, Jiang Y.
    Front Microbiol; 2021 May 21; 12():724272. PubMed ID: 34484166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.